Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues.
作者信息
Baradaran Azar
机构信息
Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.
出版信息
J Nephropathol. 2012 Oct;1(3):126-9. doi: 10.5812/nephropathol.8107. Epub 2012 Oct 1.
Abstract
摘要
相似文献
1
Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues.
J Nephropathol. 2012 Oct;1(3):126-9. doi: 10.5812/nephropathol.8107. Epub 2012 Oct 1.
2
Atherogenic lipoprotein changes in diabetic nephropathy.
Atherosclerosis. 2001 Jun;156(2):425-33. doi: 10.1016/s0021-9150(00)00673-0.
3
Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
J Diabetes Complications. 2016 Jul;30(5):923-7. doi: 10.1016/j.jdiacomp.2016.02.006. Epub 2016 Feb 12.
4
Lipoprotein abnormalities in diabetic nephropathy.
Kidney Int Suppl. 1999 Jul;71:S22-4. doi: 10.1046/j.1523-1755.1999.07106.x.
5
Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study Group.
Nephrol Dial Transplant. 2000 Dec;15(12):1971-6. doi: 10.1093/ndt/15.12.1971.
6
High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia.
Atherosclerosis. 1998 Nov;141(1):77-85. doi: 10.1016/s0021-9150(98)00150-6.
7
Nephropathy in type 2 diabetes.
J Intern Med. 1999 Feb;245(2):111-26. doi: 10.1046/j.1365-2796.1999.00411.x.
8
Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus.
Indian J Endocrinol Metab. 2014 Jan;18(1):94-8. doi: 10.4103/2230-8210.126585.
9
Abnormal lipoprotein metabolism in diabetic nephropathy.
Clin Exp Nephrol. 2014 Apr;18(2):206-9. doi: 10.1007/s10157-013-0880-y. Epub 2013 Oct 17.
10
Correlation of secreted protein acidic and rich in cysteine with diabetic nephropathy.
Int J Clin Exp Med. 2015 Aug 15;8(8):12746-55. eCollection 2015.
引用本文的文献
1
Role of Circular RNAs in Atherosclerosis through Regulation of Inflammation, Cell Proliferation, Migration, and Apoptosis: Focus on Atherosclerotic Cerebrovascular Disease.
Medicina (Kaunas). 2023 Aug 14;59(8):1461. doi: 10.3390/medicina59081461.
2
Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis.
Drug Deliv Transl Res. 2024 Feb;14(2):474-490. doi: 10.1007/s13346-023-01412-w. Epub 2023 Aug 21.
3
NORMAL FEMORAL ARTERY INTIMA-MEDIA THICKNESS AMONG HEALTHY NIGERIAN ADULTS; RELATIONSHIP WITH AGE, GENDER AND BODY MASS INDEX.
J West Afr Coll Surg. 2018 Oct-Dec;8(4):67-93.
4
Effect of Coronary Artery Bifurcation Angle on Atherosclerotic Lesion Localization Distance to the Bifurcation Site.
J Saudi Heart Assoc. 2020 Sep 1;32(3):399-407. doi: 10.37616/2212-5043.1071. eCollection 2020.
5
The contribution of syndemic conditions to cardiovascular disease risk.
AIDS Care. 2021 May;33(5):585-593. doi: 10.1080/09540121.2020.1761518. Epub 2020 May 13.
6
Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus.
Clin Pharmacol. 2019 May 9;11:57-65. doi: 10.2147/CPAA.S202614. eCollection 2019.
7
Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes.
Exp Ther Med. 2017 Jul;14(1):383-390. doi: 10.3892/etm.2017.4475. Epub 2017 May 18.
8
Herbal versus synthetic drugs; beliefs and facts.
J Nephropharmacol. 2015 Jan 1;4(1):27-30. eCollection 2015.
9
Association between serum uric acid, urinary albumin excretion, and glycated hemoglobin in Type 2 diabetic patient.
Niger Med J. 2016 Mar-Apr;57(2):119-23. doi: 10.4103/0300-1652.182074.
10
Effect of aqueous extract of Vernonia amygdalina on atherosclerosis in rabbits.
ARYA Atheroscler. 2016 Jan;12(1):35-40.
本文引用的文献
1
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.
Endocrine. 2012 Feb;41(1):89-95. doi: 10.1007/s12020-011-9544-4. Epub 2011 Oct 11.
2
Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
Eur Heart J. 2012 Feb;33(3):325-34. doi: 10.1093/eurheartj/ehr350. Epub 2011 Sep 6.
3
Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes.
Lipids. 2011 Apr;46(4):349-56. doi: 10.1007/s11745-010-3513-1. Epub 2010 Dec 14.
4
Lipoprotein(a) and risk of type 2 diabetes.
Clin Chem. 2010 Aug;56(8):1252-60. doi: 10.1373/clinchem.2010.146779. Epub 2010 May 28.
5
Lipids in association with serum magnesium in diabetes mellitus patients.
Bratisl Lek Listy. 2008;109(7):302-6.
6
Association of serum lipoprotein (a) with hypertension in diabetic patients.
Saudi J Kidney Dis Transpl. 2008 May;19(3):420-7.
7
Association of Early Atherosclerotic Vascular Changes with Serum Lipoprotein (a) in Predialysis Chronic Renal Failure and Maintenance Hemodialysis Patients.
Saudi J Kidney Dis Transpl. 2005 Apr-Jun;16(2):154-60.
8
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
JAMA. 2006 Sep 20;296(11):1363-70. doi: 10.1001/jama.296.11.1363.
9
Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria.
Diabetes Care. 2005 Jul;28(7):1718-23. doi: 10.2337/diacare.28.7.1718.
10
Association of serum lipoprotein(a) with ultrasonographically determined early atherosclerotic changes in the carotid and femoral arteries in kidney transplanted patients.
Transplant Proc. 2004 Nov;36(9):2683-6. doi: 10.1016/j.transproceed.2004.09.041.
Zotero 插件